Iveegam


Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 31.9%
Kawasaki's Disease 27.4%
Immunodeficiency 8.0%
Immunodeficiency Common Variable 5.3%
Blood Immunoglobulin M Decreased 4.4%
Colitis Ulcerative 4.4%
Hypogammaglobulinaemia 4.4%
Selective Iga Immunodeficiency 4.4%
Immunodeficiency Congenital 2.7%
Idiopathic Thrombocytopenic Purpura 1.8%
Secondary Immunodeficiency 1.8%
Acquired Haemophilia 0.9%
Peroneal Muscular Atrophy 0.9%
Prophylaxis 0.9%
Thrombocytopenia 0.9%
Therapy Non-responder 29.4%
Drug Ineffective 17.6%
Dyspnoea 9.8%
Pyrexia 9.8%
Chest Discomfort 3.9%
Tachycardia 3.9%
Blood Glucose Increased 2.0%
Bronchospasm 2.0%
Death 2.0%
Hepatitis B 2.0%
Infusion Related Reaction 2.0%
Interstitial Lung Disease 2.0%
Pelvic Pain 2.0%
Pharmaceutical Product Complaint 2.0%
Protein Total Increased 2.0%
Pulmonary Embolism 2.0%
Tremor 2.0%
Vomiting 2.0%
Wheezing 2.0%
Secondary
Drug Use For Unknown Indication 38.5%
Immunodeficiency Common Variable 9.8%
Immunodeficiency 9.4%
Blood Immunoglobulin M Decreased 9.2%
Colitis Ulcerative 9.2%
Hypogammaglobulinaemia 9.2%
Selective Iga Immunodeficiency 9.2%
Primary Immunodeficiency Syndrome 2.0%
Demyelinating Polyneuropathy 1.3%
Premedication 1.2%
Secondary Immunodeficiency 0.5%
Kawasaki's Disease 0.3%
Immunodeficiency Congenital 0.1%
Thrombocytopenia 0.1%
Transplant Rejection 0.1%
Dyspnoea 85.6%
Drug Intolerance 2.2%
Hepatitis B 2.2%
Postoperative Renal Failure 1.7%
Chest Discomfort 1.1%
Myocardial Ischaemia 1.1%
Bronchospasm 0.6%
Drug Ineffective 0.6%
Infusion Related Reaction 0.6%
Pelvic Pain 0.6%
Pulmonary Embolism 0.6%
Pyrexia 0.6%
Renal Failure 0.6%
Renal Impairment 0.6%
Tachycardia 0.6%
Therapy Non-responder 0.6%
Wheezing 0.6%
Concomitant
Multiple Myeloma 100.0%
Tooth Extraction 100.0%

Drug Data